PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Esophageal cancer is one of the most common malignant tumors, and the 5-year overall survival rate is only 20%. Esophageal squamous cell carcinoma (ESCC) is the primary histological type of esophageal carcinoma in China. Protein phosphatase 1 regulatory subunit 18 (PPP1r18) is one of the actin-regulatory proteins and is able to bind to protein phosphatase 1 catalytic subunit alpha (PPP1CA). Yet, little is known about the role of PPP1r18 in esophageal squamous cell carcinoma (ESCC). This study aimed to elucidate the biological functions of PPP1r18 in the ESCC progression. Clinical samples first confirmed that PPP1r18 expression was upregulated in ESCC, and PPP1r18 was correlated with tumor invasion depth, lymph node metastasis, distant metastasis, and reduced overall survival. We then observed that PPP1r18 overexpression enhanced cell proliferation in vitro and in vivo. Mechanistically, PPP1r18 regulated tumor progression of ESCC through activating the calcineurin-mediated ERK pathway, rather than binding to PPP1CA. Collectively, our results suggest that PPP1r18 promotes ESCC progression by regulating the calcineurin-mediated ERK pathway. PPP1r18 might be a potential target for the diagnosis and treatment of ESCC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Xie, W., Sun, Y., Zeng, Y., Hu, L., Zhi, J., Ling, H. H., Zheng, X., Ruan, X., & Gao, M. (2021) · Bioengineered · doi:10.1080/21655979.2021.2012316 · Cited by 30
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
Cohen, P. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002321 · Cited by 2,524
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Cancer metabolism: looking forward
Martínez-Reyes, I., & Chandel, N. S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,824
Calcineurin: Form and Function
Rusnak, F., & Mertz, P. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1483 · Cited by 1,373
Cited by
Jin, C., Lu, L., Gao, J., & Chen, L. (2024) · Current Molecular Medicine · doi:10.2174/0115665240312877241010123403 · Cited by 2
Schallen, K. P., Schomacker, K. T., Banila, C., Pink, H., Dest, N., & Coleman, K. L. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-56604-4 · Cited by 2
Ji, X., Yun, Y., Zhu, Z., Wu, T., Ruan, M., Fan, Y., & Zhang, Q. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04266-7
“Based on existing literature, we hypothesize that PPP1R18 may function as a scaffold protein to facilitate Src-mediated activation of the ERK pathway, given that PPP1R18 is a known binding partner of Src, a classic upstream activator of the Ras/Raf/MEK/ERK cascade [18, 21, 38–40].”
InfluentialLiu, X., Zhang, S., Wu, Z., Zhang, M., Ju, Q., Tang, X., Chen, Y., & Sun, C. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.09.001
Self-citationBiogenic magnetic nanoparticles as regulators of mechanosensitive calcium signaling in tumors
Salatskyi, Y., Gorobets, S., & Gorobets, O. (2026) · Regulatory Mechanisms in Biosystems · doi:10.15421/0226164
Metadata
- Authors
- Ren, C., Wu, L., Zhang, S., Qi, K., Zhang, Y., Xu, J., Ruan, Y., & Feng, M.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Fudan University (CN)
- Corresponding author
- Ruan, Yuanyuan
- Feng, Mingxiang
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-05-08
- Volume
- 45
- Issue
- 9
- Pages
- 673-684
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W4396726142
- Cited by
- 5
- References
- 49
- Citations by year
- 2026: 4 · 2024: 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Carcinogenesis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Technology Commission of Shanghai Municipality (20Y11908200)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- esophageal squamous cell carcinoma, calcineurin, ERK signaling, tumor progression, tumor invasion, lymph node metastasis, distant metastasis, cell proliferation, PPP1CA, prognostic factors, therapeutic target
- MeSH terms
- Esophageal Squamous Cell Carcinoma, Animals, Cell Movement, Esophageal Neoplasms, Female, Humans, Lymphatic Metastasis, Male, Mice, Nude, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, Disease Progression, Calcineurin, MAP Kinase Signaling System, Xenograft Model Antitumor Assays, Cell Line, Tumor, Cell Proliferation, Mice, Protein Phosphatase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway. https://app.cochat.ai/papers/10.1093/carcin/bgae028
- The paper
- Ren, C., Wu, L., Zhang, S., Qi, K., Zhang, Y., Xu, J., Ruan, Y., & Feng, M. (2024). PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway. Carcinogenesis. https://doi.org/10.1093/carcin/bgae028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.